Holen Sie sich die Stockscreener-App
62.00
2.07%
1.26
Schlusskurs vom Vortag:
$60.74
Offen:
$60.66
24-Stunden-Volumen:
2.98M
Relative Volume:
1.35
Marktkapitalisierung:
$9.45B
Einnahmen:
$3.46B
Nettoeinkommen (Verlust:
$-9.40M
KGV:
-257.90
EPS:
-0.2404
Netto-Cashflow:
$51.30M
1W Leistung:
+4.90%
1M Leistung:
-2.02%
6M Leistung:
+70.99%
1J Leistung:
+60.12%
1-Tages-Spanne:
$60.55
$63.39
1-Wochen-Bereich:
$55.32
$63.39
52-Wochen-Spanne:
$32.37
$66.98
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
62.00 | 9.45B | 3.46B | -9.40M | 51.30M | -0.2404 |
ABT
Abbott Laboratories
|
102.64 | 177.61B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.78 | 121.24B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
304.00 | 116.61B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.43 | 61.49B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
91.78 | 52.90B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2026-09-09 | Eingeleitet | UBS | Neutral |
| 2026-06-02 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Eingeleitet | Goldman | Sell |
| 2025-11-20 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Bruker Corporation Estimates – NASDAQ:BRKR - TradingView
Bruker Corporation (BRKR) Stock Forecasts - Yahoo! Finance Canada
Bruker Corp (BRKR) Stock Forum and Discussion - Moomoo
Is It Too Late to Buy Bruker Corp (BRKR) After 5.7% Rally? GF Va - GuruFocus
Bruker Corporation (BRKR) Stock Forecasts - Yahoo Finance
Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast - Yahoo Finance
J.P. Morgan Downgrades Bruker Corporation (BRKR) to Neutral Amid Revenue Growth Concerns - GuruFocus
Bruker, Sotera downgraded at J.P. Morgan (BRKR:NASDAQ) - Seeking Alpha
Bruker Gains 66.3% in a Year: What's Driving the Rally? - Zacks Investment Research
Bruker Gains 66.3% in a Year: What's Driving the Rally? - Yahoo Finance
Bruker announces proteome atlas: Bruker stock gains 1.14 percent - AD HOC NEWS
Bruker Corp (BRKR) Shares Fall 5.3% -- GF Value Says Still Overv - GuruFocus
Bruker Drops 6.5% Amid Sector-Wide Selling - AlphaStreet
Bruker (NASDAQ:BRKR) Stock Price Down 6.5%Time to Sell? - MarketBeat
Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution - Business Wire
Bruker stock adds a USD 6 million UC Berkeley order - AD HOC NEWS
Bruker Corporation (BRKR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Are Options Traders Betting on a Big Move in Bruker Stock? - TradingView
Are Options Traders Betting on a Big Move in Bruker Stock? - Zacks Investment Research
Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley - Moomoo
Bruker Stock Price Forecast. Should You Buy BRKR? - StockInvest.us
Why Bruker (BRKR) is a Top Momentum Stock for the Long-Term - Zacks Investment Research
Bruker Corp (BRKR) Shares Fall 4.3% -- GF Value Says Still Overv - GuruFocus
Bruker Slides as No Fresh Catalyst Emerges and Broader Risk-Off Mood Weighs - Quiver Quantitative
Bruker Corporation (BRKR) Stock Forecasts - Yahoo Finance
Bruker (NASDAQ:BRKR) Sets New 52-Week HighShould You Buy? - MarketBeat
Bruker Corporation stock hits 52-week high at 65.48 USD By Investing.com - Investing.com South Africa
Bruker Corporation stock hits 52-week high at 65.48 USD - Investing.com
Bruker (BRKR) Sets a New 52-Week High at $64.51 - 24/7 Wall St.
Long term debt to total assets ratio of Bruker Corporation – HAN:BKD - TradingView
Total liabilities & shareholders' equities of Bruker Corporation – HAN:BKD - TradingView
Bruker Corporation (BRKRP) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bruker (BRKR) Unveils Advanced Protein-Sequence Analysis Workflo - GuruFocus
Bruker Corporation Announces New Timsultra Aip and Timsomni Workflows for Drug Discovery and Development and Disease Biology Research - marketscreener.com
Bruker unveils proteomics workflows at HUPO congress - Investing.com
MA-BRUKER-CORPORATION - The Facts
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research - Rutland Herald
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research - bdtonline.com
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research - Business Wire
BRKR 10-Q FilingsBruker Corporation SEC 10-Q - Stock Titan
Bruker Sees AI-Fueled Semiconductor Demand, Targets Critical Q4 Revenue Rebound - Yahoo Finance
Bruker (BRKR) surges nearly 10% in a single session - 24/7 Wall St.
Bruker Corporation (BRKR) Stock Forecasts - Yahoo Finance
Automated Microscopy Market Advances as AI-Powered Image Analysis Transforms Digital Pathology and Semiconductor Inspection - GlobeNewswire Inc.
Global Metabolomics Market to Reach US$9.01 Billion by 2035 as Precision Medicine, Biomarker Discovery and Advanced Analytics Unlock New Opportunities - GlobeNewswire Inc.
Is Bruker (BRKR) Using Flagship Academic NMR Deals To Deepen Its High-End Moat? - Yahoo Finance
Bruker Gets More Than $6 Million Order From University of California, Berkeley - Yahoo Finance
55,937 Shares in Bruker Corporation $BRKR Purchased by Squarepoint Ops LLC - MarketBeat
Bruker Corporation at Wells Fargo Healthcare Conference Transcript - GuruFocus
Wellington Management Group LLP Invests $1.36 Million in Bruker Corporation $BRKR - MarketBeat
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bruker Corp-Aktie (BRKR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MARK R MUNCH | Officer |
Sep 15 '26 |
Proposed Sale |
52.87 |
2,000 |
105,740 |
0 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Sep 15 '26 |
Sale |
52.87 |
2,000 |
105,740 |
134,806 |
| Pusch Wolfgang | President BMID Group |
Aug 17 '26 |
Sale |
56.90 |
3,473 |
197,614 |
9,801 |
| WOLFGANG PUSCH | Officer |
Aug 17 '26 |
Proposed Sale |
56.90 |
3,473 |
197,614 |
0 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Aug 14 '26 |
Option Exercise |
22.19 |
2,000 |
44,380 |
125,347 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Aug 14 '26 |
Sale |
57.60 |
2,000 |
115,200 |
123,347 |
| MARK R MUNCH | Officer |
Aug 14 '26 |
Proposed Sale |
57.60 |
2,000 |
115,200 |
0 |
| MARK R MUNCH | Officer |
Jul 15 '26 |
Proposed Sale |
60.25 |
2,000 |
120,500 |
0 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Jul 15 '26 |
Option Exercise |
22.19 |
2,000 |
44,380 |
130,443 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Jul 15 '26 |
Sale |
60.25 |
2,000 |
120,500 |
128,443 |
4.22%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):